Related Experiment Videos

Breast cancer--do we need to change the model?

A K Goel¹, V Seenu

¹Department of Surgery, All India Institute of Medical Sciences, New Delhi.

The National Medical Journal of India

|January 1, 1994

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Evaluating Single Agent Indocyanine Green as an Alternative to Dual Dye-Tracer Mapping in Sentinel Lymph Node Biopsy for Breast Cancer: A Two-Arm Open-Label Randomized Controlled Trial.

World journal of surgery·2026

A phase II, randomized, open-label study to evaluate low-dose pembrolizumab plus chemotherapy versus chemotherapy as neoadjuvant therapy for localized triple-negative breast cancer (TNBC) (PLANeT trial-Pembrolizumab Low dose in Addition to NACT in TNBC).

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Parathyroid Adenoma with Macrofollicular Growth Pattern: A Rare Histopathological Entity.

Journal of the ASEAN Federation of Endocrine Societies·2025

Delay from Onset of Symptoms to Reporting at a Cancer Care Facility and the Impact of Alternate Medicine Usage as a Contributing Factor.

South Asian journal of cancer·2025

An Innovative Low Cost Technique of Hand Port Creation for Hand Assisted Laparoscopic Surgery (HALS)- the AIIMS Technique.

Surgical innovation·2025

A phase II, randomized, open-labeled study to evaluate low-dose pembrolizumab in addition to neoadjuvant chemotherapy for triple-negative breast cancer (TNBC).

Trials·2025

See all related articles